Hypera S.A., which operates as Hypera Pharma, is a Brazilian pharmaceutical company focused on the domestic market. The company is dedicated to the development, production and sale of a wide portfolio of pharmaceutical products, with a presence in almost every point of sale in Brazil. Its operations cover all pharmaceutical retail segments, with a portfolio of leading brands highlighted. The company also operates in the Institutional Market, which includes public sector sales. The business model is supported by investments in innovation, new product launches in its business units, and the expansion of production capacity. The company invests in the production of strategic inputs and in new plants for products such as oncology and biologics to support its growth. Fonts
Revenue Compound Annual Growth Rate in the last 5 years.
Operating Income Compound Annual Growth Rate in the last 5 years.
Net Income Compound Annual Growth Rate in the last 5 years.
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
...and much more!